Education
Ph.D., Centre of Molecular Neurobiology Hamburg (ZMNH), University of Hamburg, 2005
Current position
Research Group leader, Institute of Pharmacology and Toxicology, University Medical of Goettingen, Goettingen
Publications
-
Zafiriou, M. P., Noack, C., Unsold, B., Didie, M., Pavlova, E., Fischer, H. J., Reichardt, H. M., Bergmann, M. W., El-Armouche, A., Zimmermann, W. H. and Zelarayan, L. C. (2014). Erythropoietin responsive cardiomyogenic cells contribute to heart repair post myocardial infarction. Stem Cells 32(9): 2480-2491.
-
Kararigas, G., Nguyen, B. T., Zelarayan, L. C., Hassenpflug, M., Toischer, K., Sanchez-Ruderisch, H., Hasenfuss, G., Bergmann, M. W., Jarry, H. and Regitz-Zagrosek, V. (2014). Genetic background defines the regulation of postnatal cardiac growth by 17beta-estradiol through a beta-catenin mechanism. Endocrinology 155(7): 2667-2676.
-
Renger, A., Zafiriou, M. P., Noack, C., Pavlova, E., Becker, A., Sharkova, K., Bergmann, M. W., El-Armouche, A., Zimmermann, W. H. and Zelarayan, L. C. (2013). The four and a half LIM-domain 2 controls early cardiac cell commitment and expansion via regulating beta-catenin-dependent transcription. Stem Cells 31(5): 928-940.
-
Zelarayan, L. C., Zafiriou, M. P. and Zimmermann, W. H. (2013). Emerging Concepts in Myocardial Pharmacoregeneration. In: Steinhoff, Gustav (Ed.). Regenerative Medicine- From Protocol to Patient. 25. Netherland: Springer
-
Noack, C., Zafiriou, M. P., Schaeffer, H. J., Renger, A., Pavlova, E., Dietz, R., Zimmermann, W. H., Bergmann, M. W. and Zelarayan, L. C. (2012). Krueppel-like factor 15 regulates Wnt/beta-catenin transcription and controls cardiac progenitor cell fate in the postnatal heart. EMBO Mol Med 4(9): 992-1007.
-
Zafiriou, M. P., Zelarayan, L. C., Noack, C., Renger, A., Nigam, S. and Siafaka-Kapadai, A. (2011). Hepoxilin A(3) protects beta-cells from apoptosis in contrast to its precursor, 12-hydroperoxyeicosatetraenoic acid. Biochim Biophys Acta 1811(6): 361-369.
-
Honore, S. M., Zelarayan, L. C., Genta, S. B. and Sanchez, S. S. (2011). Neuronal loss and abnormal BMP/Smad signaling in the myenteric plexus of diabetic rats. Auton Neurosci 164(1-2): 51-61.
-
Zelarayan, L. C., Noack, C., Zafiriou, M. P., Renger, A. and Bergmann, M. W. (2010). Wnt signaling molecules in left ventricular remodeling: focus on dishevelled 1. Hypertension 55(4): 852-854.
-
Zelarayan, L., Renger, A., Noack, C., Zafiriou, M. P., Gehrke, C., van der Nagel, R., Dietz, R., de Windt, L. and Bergmann, M. W. (2009). NF-kappaB activation is required for adaptive cardiac hypertrophy. Cardiovasc Res 84(3): 416-424.
-
Bergmann, M. W. and Zelarayan, L. (2009). RALT specifically halts maladaptive cardiac hypertrophy: a new kid on the block. Hypertension 53(3): 454-455.
-
Dominguez-Frutos, E., Vendrell, V., Alvarez, Y., Zelarayan, L. C., Lopez-Hernandez, I., Ros, M. and Schimmang, T. (2009). Tissue-specific requirements for FGF8 during early inner ear development. Mech Dev 126(10): 873-881.
-
Zelarayan, L. C., Noack, C., Sekkali, B., Kmecova, J., Gehrke, C., Renger, A., Zafiriou, M. P., van der Nagel, R., Dietz, R., de Windt, L. J., Balligand, J. L. and Bergmann, M. W. (2008). Beta-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation. Proc Natl Acad Sci U S A 105(50): 19762-19767.
-
Bergmann, M. W., Zelarayan, L. and Gehrke, C. (2008). Treatment-sensitive premature renal and heart senescence in hypertension. Hypertension 52(1): 61-62.
-
Baurand, A., Zelarayan, L., Betney, R., Gehrke, C., Dunger, S., Noack, C., Busjahn, A., Huelsken, J., Taketo, M. M., Birchmeier, W., Dietz, R. and Bergmann, M. W. (2007). Beta-catenin downregulation is required for adaptive cardiac remodeling. Circ Res 100(9): 1353-1362
-
Zelarayan, L., Gehrke, C. and Bergmann, M. W. (2007). Role of beta-catenin in adult cardiac remodeling. Cell Cycle 6(17): 2120-2126.
-
Zelarayan, L. C., Vendrell, V., Alvarez, Y., Dominguez-Frutos, E., Theil, T., Alonso, M. T., Maconochie, M. and Schimmang, T. (2007). Differential requirements for FGF3, FGF8 and FGF10 during inner ear development. Dev Biol 308(2): 379-391.
-
Wang, X. P., Suomalainen, M., Felszeghy, S., Zelarayan, L. C., Alonso, M. T., Plikus, M. V., Maas, R. L., Chuong, C. M., Schimmang, T. and Thesleff, I. (2007). An integrated gene regulatory network controls stem cell proliferation in teeth. PLoS Biol 5(6): e159.
-
Carnicero, E., Zelarayan, L. C., Ruttiger, L., Knipper, M., Alvarez, Y., Alonso, M. T. and Schimmang, T. (2004). Differential roles of fibroblast growth factor-2 during development and maintenance of auditory sensory epithelia. J Neurosci Res 77(6): 787-797.
-
Alvarez, Y., Alonso, M. T., Vendrell, V., Zelarayan, L. C., Chamero, P., Theil, T., Bosl, M. R., Kato, S., Maconochie, M., Riethmacher, D. and Schimmang, T. (2003). Requirements for FGF3 and FGF10 during inner ear formation. Development 130(25): 6329-6338.
-
Honoré, S. M., Zelarayán, L. C., Genta, S. B., Villecco, E. I. and Sánchez, S. S. (2008). Down regulation of gap junctions and cadherin/beta-catenin complexes in diabetic small intestine. Biocell. 32:P55:76. (IF 0,57) (H: 21)
-
Honoré, S. M., Zelarayán, L. C., Genta, S. B., Villecco, E. I. and Sánchez, S. S. (2007). Experimental diabetes alters cell-cell contacts in intestinal smooth muscle layer. Biocell 31:P18:80. (IF 0,57) (H: 21)
-
Fuentes, A., Genta, S. B., Aybar, M., Zelarayán, L. C., Cabrera, W. and Sánchez, S. S. (2001). Victronectin mRNA expression during Amphibian embryo development. Biocell 1:106:25. (IF 0,57) (H: 21)